Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: Potential therapeutic considertions

American Journal of Therapeutics

Volumn 19, Issue 1, 2012, Pages 44-50

  Kuliczkowski, Wiktor ^a   Derzhko, Roksolana ^a   Prajs, Iwona ^a   Podolak Dawidziak, Maria ^a   Serebruany, Victor L ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

endothelial progenitor cells; left ventricle function; myocardial infarction; percutaneous coronary intervention

Indexed keywords

C REACTIVE PROTEIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; FIBRINOGEN; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ANTERIOR MYOCARDIAL INFARCTION; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FIBRINOGEN BLOOD LEVEL; FLOW CYTOMETRY; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL MOBILIZATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIGENS, CD; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STEM CELLS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 79953067211     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181e0cab3     Document Type: Review

References (25)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967. (Pubitemid 27087709)
2. Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449-1457. (Pubitemid 40615617)
3. Fadini GP, Coracina A, Baesso I, et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke. 2006;37:2277-2282. (Pubitemid 44337169)
4. Fadini GP, Sartore S, Albiero M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol. 2006;26:2140-2146. (Pubitemid 44253800)
5. Fadini GP, de Kreutzenberg SV, Coracina A, et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J. 2006;27:2247-2255. (Pubitemid 44412842)
6. Fadini GP, Agostini C, Sartore S, et al. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis. 2007;194:46-54. (Pubitemid 47464318)
7. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600. (Pubitemid 36204953)
8. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111:2981-2987. (Pubitemid 40814192)
9. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007. (Pubitemid 41262334)
10. Rosenzweig A. Circulating endothelial progenitors-cells as biomarkers. N Engl J Med. 2005;353:1055-1057.
11. Dill T, Schachinger V, Rolf A, et al. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J. 2009;157:541-547.
12. Tendera M, Wojakowski W, Ruzyllo W, et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009;30:1313-1321.
13. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOSTrandomised controlled clinical trial. Lancet. 2004;364:141-148. (Pubitemid 38891685)
14. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212-2218. (Pubitemid 37368893)
15. Tatsumi T, Ashihara E, Yasui T, et al. Intracoronary transplantation of non-expanded peripheral bloodderived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J. 2007;71:1199-1207. (Pubitemid 47201778)
16. Leone AM, Rutella S, Bonanno G, et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J. 2005;26: 1196-1204. (Pubitemid 40863126)
17. Leone AM, Rutella S, Giannico MB, et al. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Int J Cardiol. 2008;130:457-462.
18. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. (Pubitemid 41821197)
19. Yu CM, Lin H, Yang H, et al. Progression of systolic abnormalities in patientswith 'isolated'diastolic heart failure and diastolic dysfunction. Circulation. 2002;105:1195-1201. (Pubitemid 34225820)
20. Fadini GP, Baesso I, Albiero M, et al. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis. 2008;197:496-503.
21. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103:2776-2779. (Pubitemid 32550062)
22. Banerjee S, Brilakis E, Zhang S, et al. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis. 2006;189:70-75. (Pubitemid 44441298)
23. Massa M, Rosti V, Ferrario M, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood. 2005; 105:199-206. (Pubitemid 40053083)
24. Wojakowski W, Tendera M, Michalowska A, et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004;110:3213-3220. (Pubitemid 39525068)
25. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149-150.